Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | 5.04% |
| Q1 2025 | 95.22% |
| Q4 2024 | -88.84% |
| Q3 2024 | 87.60% |
| Q2 2024 | 374.80% |
| Q1 2024 | 97.65% |
| Q4 2023 | -3606.00% |
| Q3 2023 | 102.89% |
| Q2 2023 | -0.59% |
| Q1 2023 | -21.35% |
| Q4 2022 | -0.57% |
| Q3 2022 | -2.90% |
| Q2 2022 | -21.83% |
| Q1 2022 | -17.69% |
| Q4 2021 | -7.01% |
| Q3 2021 | -51.01% |
| Q2 2021 | 26.25% |
| Q1 2021 | -81.25% |
| Q4 2020 | 33.86% |
| Q3 2020 | -6.03% |
| Q2 2020 | -5.60% |
| Q1 2020 | 5.13% |
| Q4 2019 | 10.45% |
| Q3 2019 | -12.69% |
| Q2 2019 | 3.70% |
| Q1 2019 | -15.20% |
| Q4 2018 | 23.08% |
| Q3 2018 | 41.25% |
| Q2 2018 | -4.93% |
| Q1 2018 | 11.00% |
| Q4 2017 | -11.21% |
| Q3 2017 | 15.02% |
| Q2 2017 | 12.73% |
| Q1 2017 | -1395.19% |
| Q4 2016 | 104.02% |
| Q3 2016 | 3.18% |
| Q2 2016 | 3.64% |
| Q1 2016 | -167.52% |
| Q4 2015 | 2.10% |